All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF6 | Anti-Human ALPP (XW-06) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-06 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF7 | Anti-Human ALPP (XW-07) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-07 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8 | Anti-Mouse ALPP (XW-08) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-08 | Rabbit | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF9 | Anti-Mouse ALPP (XW-09) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-09 | Rabbit | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF10 | Anti-Human ALPP (XW-10) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-10 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF11 | Anti-Human ALPP (XW-11) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-11 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF12 | Anti-Human ALPP (XW-12) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-12 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF926 | Anti-Human ALPP (XW-06) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-06 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF927 | Anti-Human ALPP (XW-07) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-07 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF928 | Anti-Mouse ALPP (XW-08) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-08 | Rabbit | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF929 | Anti-Mouse ALPP (XW-09) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-09 | Rabbit | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF930 | Anti-Human ALPP (XW-10) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-10 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF931 | Anti-Human ALPP (XW-11) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-11 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF932 | Anti-Human ALPP (XW-12) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-12 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1846 | Anti-Human ALPP (XW-06) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-06 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1847 | Anti-Human ALPP (XW-07) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-07 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1848 | Anti-Mouse ALPP (XW-08) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-08 | Rabbit | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1849 | Anti-Mouse ALPP (XW-09) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-09 | Rabbit | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1850 | Anti-Human ALPP (XW-10) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-10 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1851 | Anti-Human ALPP (XW-11) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-11 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION